BRPI0413190A - múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário - Google Patents

múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário

Info

Publication number
BRPI0413190A
BRPI0413190A BRPI0413190-8A BRPI0413190A BRPI0413190A BR PI0413190 A BRPI0413190 A BR PI0413190A BR PI0413190 A BRPI0413190 A BR PI0413190A BR PI0413190 A BRPI0413190 A BR PI0413190A
Authority
BR
Brazil
Prior art keywords
high resolution
ovarian cancer
sensitivity
resolution mass
spectral data
Prior art date
Application number
BRPI0413190-8A
Other languages
English (en)
Inventor
Peter A Levine
Ben A Hitt
Lance A Liotta
Emanuel F Petricoin
Original Assignee
Correlogic Systems Inc
Government Of The Unidet State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Correlogic Systems Inc, Government Of The Unidet State filed Critical Correlogic Systems Inc
Publication of BRPI0413190A publication Critical patent/BRPI0413190A/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Signal Processing (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"MULTIPLAS CARACTERìSTICAS PROTEÈMICAS SéRICAS DE ALTA RESOLUçãO PARA DETECçãO DE CáNCER DE OVáRIO". A presente invenção refere-se a um conjunto de estudo de soro bem controlado (n = 248) de mulheres, acompanhadas e avaliadas quanto à presença de câncer de ovário foi utilizado para estender a análise do padrão proteómico de soropara uma plataforma de instrumento espectrómetro de massa de alta resolução, para explorar a existência de conjuntos de características diagnósticas altamente precisas distintas múltiplas presentes no mesmo espectro de massa. Conjuntos de características proteómicas diagnósticas altamente precisas existem dentro de espectro de massa de soros humanos. Utilizando dados espectrais de massa de alta resolução, pelo menos 56 diferentes padrões foram descobertos, que alcançam mais de 85% de sensibilidade e especificamente na testagem e avaliação. Quatro dos conjuntos de características apresentaram 100% de sensibilidade e especificidade em validação vendada. A sensibilidade e a especificidade de modelos diagnósticos gerados a partir de dados espectrais de massa de alta resolução foram superiores a (p< 0,00001) àquelas de dados espectrais de massa de baixa resolução utilizando a mesma amostra de entrada.
BRPI0413190-8A 2003-08-01 2004-07-30 múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário BRPI0413190A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49152403P 2003-08-01 2003-08-01
US90242704A 2004-07-30 2004-07-30
PCT/US2004/024413 WO2005011474A2 (en) 2003-08-01 2004-07-30 Multiple high-resolution serum proteomic features for ovarian cancer detection

Publications (1)

Publication Number Publication Date
BRPI0413190A true BRPI0413190A (pt) 2006-10-03

Family

ID=34118868

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413190-8A BRPI0413190A (pt) 2003-08-01 2004-07-30 múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário

Country Status (11)

Country Link
US (1) US20060064253A1 (pt)
EP (1) EP1649281A4 (pt)
JP (1) JP2007501380A (pt)
AU (1) AU2004261222A1 (pt)
BR (1) BRPI0413190A (pt)
CA (1) CA2534336A1 (pt)
EA (1) EA200600346A1 (pt)
IL (1) IL173471A0 (pt)
MX (1) MXPA06001170A (pt)
SG (1) SG145705A1 (pt)
WO (1) WO2005011474A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1249620C (zh) 2000-06-19 2006-04-05 科雷洛吉克系统公司 分类试探方法
WO2004011905A2 (en) * 2002-07-29 2004-02-05 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
JP2008530555A (ja) * 2005-02-09 2008-08-07 コレロジック システムズ，インコーポレイテッド 細菌及び芽胞の同定
WO2006124628A2 (en) * 2005-05-12 2006-11-23 Correlogic Systems, Inc. A model for classifying a biological sample in relation to breast cancer based on mass spectral data
US7972802B2 (en) 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US7736905B2 (en) 2006-03-31 2010-06-15 Biodesix, Inc. Method and system for determining whether a drug will be effective on a patient with a disease
WO2008037479A1 (en) * 2006-09-28 2008-04-03 Private Universität Für Gesundheitswissenschaften Medizinische Informatik Und Technik - Umit Feature selection on proteomic data for identifying biomarker candidates
EP2115458A4 (en) * 2007-02-01 2011-06-08 Phenomenome Discoveries Inc METHOD FOR DIAGNOSIS OF HEALTH CONDITIONS FOR OVARIAL CARCINOMA AND THE RISK OF HEALTH CONDITIONS IN OVARIAL CARCINOMA
WO2008100941A2 (en) * 2007-02-12 2008-08-21 Correlogic Systems Inc. A method for calibrating an analytical instrument
US8664358B2 (en) 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
CN102770760A (zh) * 2010-02-24 2012-11-07 佰欧迪塞克斯公司 利用质谱分析选择施用治疗剂的癌症患者
KR20140024860A (ko) 2011-02-24 2014-03-03 버밀리언, 인코포레이티드 난소암에 대한 바이오마커 패널，진단 방법 및 시험 키트
KR101439975B1 (ko) 2012-01-03 2014-11-21 국립암센터 대장암 진단 장치
KR101439981B1 (ko) 2012-01-03 2014-09-12 국립암센터 유방암 진단 장치
KR101439977B1 (ko) 2012-01-03 2014-09-12 국립암센터 위암 진단 장치
WO2013103197A1 (ko) * 2012-01-03 2013-07-11 국립암센터 암 진단 장치
EP2741224A1 (en) * 2012-11-20 2014-06-11 Thermo Finnigan LLC Methods for generating local mass spectral libraries for interpreting multiplexed mass spectra
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935562A (en) * 1974-02-22 1976-01-27 Stephens Richard G Pattern recognition method and apparatus
US4075475A (en) * 1976-05-03 1978-02-21 Chemetron Corporation Programmed thermal degradation-mass spectrometry analysis method facilitating identification of a biological specimen
US4122518A (en) * 1976-05-17 1978-10-24 The United States Of America As Represented By The Administrator Of The National Aeronautics & Space Administration Automated clinical system for chromosome analysis
US4697242A (en) * 1984-06-11 1987-09-29 Holland John H Adaptive computing system capable of learning and discovery
US4881178A (en) * 1987-05-07 1989-11-14 The Regents Of The University Of Michigan Method of controlling a classifier system
US5697369A (en) * 1988-12-22 1997-12-16 Biofield Corp. Method and apparatus for disease, injury and bodily condition screening or sensing
WO1991014990A1 (en) * 1990-03-28 1991-10-03 Koza John R Non-linear genetic algorithms for solving problems by finding a fit composition of functions
US5210412A (en) * 1991-01-31 1993-05-11 Wayne State University Method for analyzing an organic sample
US5784162A (en) * 1993-08-18 1998-07-21 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for biological research, medical diagnostics and therapy
US5632957A (en) * 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6114114A (en) * 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
DE69333288T2 (de) * 1992-09-01 2004-08-26 Apple Computer, Inc., Cupertino Verbesserte vektorquantisierung
EP0700521B1 (en) * 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
US5995645A (en) * 1993-08-18 1999-11-30 Applied Spectral Imaging Ltd. Method of cancer cell detection
US5352613A (en) * 1993-10-07 1994-10-04 Tafas Triantafillos P Cytological screening method
US5553616A (en) * 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US6025128A (en) * 1994-09-29 2000-02-15 The University Of Tulsa Prediction of prostate cancer progression by analysis of selected predictive parameters
WO1996012187A1 (en) * 1994-10-13 1996-04-25 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
US5848177A (en) * 1994-12-29 1998-12-08 Board Of Trustees Operating Michigan State University Method and system for detection of biological materials using fractal dimensions
GB2301897B (en) * 1995-06-08 1999-05-26 Univ Wales Aberystwyth The Composition analysis
KR100197580B1 (ko) * 1995-09-13 1999-06-15 이민화 무선 통신망을 이용한 실시간 생체신호모니터링시스템
US5716825A (en) * 1995-11-01 1998-02-10 Hewlett Packard Company Integrated nucleic acid analysis system for MALDI-TOF MS
US5687716A (en) * 1995-11-15 1997-11-18 Kaufmann; Peter Selective differentiating diagnostic process based on broad data bases
DE19543020A1 (de) * 1995-11-18 1997-05-22 Boehringer Mannheim Gmbh Verfahren und Vorrichtung zur Bestimmung von analytischen Daten über das Innere einer streuenden Matrix
US5760761A (en) * 1995-12-15 1998-06-02 Xerox Corporation Highlight color twisting ball display
US5839438A (en) * 1996-09-10 1998-11-24 Neuralmed, Inc. Computer-based neural network system and method for medical diagnosis and interpretation
US6295514B1 (en) * 1996-11-04 2001-09-25 3-Dimensional Pharmaceuticals, Inc. Method, system, and computer program product for representing similarity/dissimilarity between chemical compounds
US6571227B1 (en) * 1996-11-04 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Method, system and computer program product for non-linear mapping of multi-dimensional data
EP1164203B1 (en) * 1996-11-06 2007-10-10 Sequenom, Inc. DNA Diagnostics based on mass spectrometry
US6157921A (en) * 1998-05-01 2000-12-05 Barnhill Technologies, Llc Enhancing knowledge discovery using support vector machines in a distributed network environment
IL131843A (en) * 1997-03-24 2004-06-20 Univ Kingston A method for detecting coincidences, products and devices
US5905258A (en) * 1997-06-02 1999-05-18 Advanced Research & Techology Institute Hybrid ion mobility and mass spectrometer
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6081797A (en) * 1997-07-09 2000-06-27 American Heuristics Corporation Adaptive temporal correlation network
US5974412A (en) * 1997-09-24 1999-10-26 Sapient Health Network Intelligent query system for automatically indexing information in a database and automatically categorizing users
US6085576A (en) * 1998-03-20 2000-07-11 Cyrano Sciences, Inc. Handheld sensing apparatus
US6723564B2 (en) * 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
WO2000025192A2 (en) * 1998-10-26 2000-05-04 Visionary Medical, Inc. Prescription-controlled data collection system and method
US5989824A (en) * 1998-11-04 1999-11-23 Mesosystems Technology, Inc. Apparatus and method for lysing bacterial spores to facilitate their identification
US6631333B1 (en) * 1999-05-10 2003-10-07 California Institute Of Technology Methods for remote characterization of an odor
US7057168B2 (en) * 1999-07-21 2006-06-06 Sionex Corporation Systems for differential ion mobility analysis
US6329652B1 (en) * 1999-07-28 2001-12-11 Eastman Kodak Company Method for comparison of similar samples in liquid chromatography/mass spectrometry
US6615199B1 (en) * 1999-08-31 2003-09-02 Accenture, Llp Abstraction factory in a base services pattern environment
CN1249620C (zh) * 2000-06-19 2006-04-05 科雷洛吉克系统公司 分类试探方法
US6680203B2 (en) * 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
WO2002007064A2 (en) * 2000-07-17 2002-01-24 Labnetics, Inc. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
US6925389B2 (en) * 2000-07-18 2005-08-02 Correlogic Systems, Inc., Process for discriminating between biological states based on hidden patterns from biological data
AU2002245043B2 (en) * 2000-11-16 2006-10-26 Bio-Rad Laboratories, Inc. Method for analyzing mass spectra
WO2002061047A2 (en) * 2001-02-01 2002-08-08 Ciphergen Biosystems, Inc. Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry
US7299134B2 (en) * 2001-02-16 2007-11-20 Bio-Rad Laboratories, Inc. Method for correlating gene expression profiles with protein expression profiles
CN1463291A (zh) * 2001-04-19 2003-12-24 赛弗根生物系统股份有限公司 用质谱法和亲和标记物鉴定生物分子的特性
EP1421381A1 (en) * 2001-08-03 2004-05-26 The General Hospital Corporation System, process and diagnostic arrangement establishing and monitoring medication doses for patients
WO2003017177A2 (en) * 2001-08-13 2003-02-27 Beyong Genomics, Inc. Method and system for profiling biological systems
AU2003235749A1 (en) * 2002-01-07 2003-07-24 John Hopkins University Biomarkers for detecting ovarian cancer
US20020193950A1 (en) * 2002-02-25 2002-12-19 Gavin Edward J. Method for analyzing mass spectra
WO2004011905A2 (en) * 2002-07-29 2004-02-05 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
JP4585167B2 (ja) * 2002-11-29 2010-11-24 東芝医用システムエンジニアリング株式会社 Ｘ線コンピュータ断層撮影システム
CA2548842A1 (en) * 2003-12-11 2005-07-07 Correlogic Systems, Inc. Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
JP2008530555A (ja) * 2005-02-09 2008-08-07 コレロジック システムズ，インコーポレイテッド 細菌及び芽胞の同定

Also Published As

Publication number Publication date
EA200600346A1 (ru) 2006-08-25
WO2005011474A3 (en) 2005-06-09
CA2534336A1 (en) 2005-02-10
EP1649281A2 (en) 2006-04-26
US20060064253A1 (en) 2006-03-23
SG145705A1 (en) 2008-09-29
AU2004261222A1 (en) 2005-02-10
JP2007501380A (ja) 2007-01-25
IL173471A0 (en) 2006-06-11
WO2005011474A2 (en) 2005-02-10
AU2004261222A2 (en) 2005-02-10
MXPA06001170A (es) 2006-05-15
EP1649281A4 (en) 2007-11-07

Similar Documents

Publication Publication Date Title
BRPI0413190A (pt) múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário
Wong et al. Periodontal disease and quality of life: Umbrella review of systematic reviews
Prentice et al. A physically motivated classification of stripped-envelope supernovae
Mikkonen et al. Salivary metabolomics in the diagnosis of oral cancer and periodontal diseases
Witjes et al. Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
Remark et al. In-depth tissue profiling using multiplexed immunohistochemical consecutive staining on single slide
Sallam Proteomics in cancer biomarkers discovery: challenges and applications
Zhou et al. Metabolomic profiling of mice serum during toxoplasmosis progression using liquid chromatography-mass spectrometry
Janneh et al. Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients
Beckwith-Hall et al. NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the rat
Ghosh et al. Search for allergens from the pollen proteome of sunflower (Helianthus annuus L.): a major sensitizer for respiratory allergy patients
WO2005054853A3 (en) Method for diagnosing diseases based on levels of anti-glycan antibodies
CA2619732A1 (en) Methods for the diagnosis of colorectal cancer and ovarian cancer health states
Roberts et al. Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303)
Wang et al. Identifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks
Sun et al. Protein classifier for thyroid nodules learned from rapidly acquired proteotypes
Cao et al. Database-assisted global metabolomics profiling of pleural effusion induced by tuberculosis and malignancy
Randolph et al. Quantifying peptide signal in MALDI-TOF mass spectrometry data
Zhao et al. Positivity of both plasma Epstein–Barr virus DNA and serum Epstein–Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma
Perzanowska et al. An MRM‐Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions
Kirkegård et al. Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation: J. Kirkegård et al.
Zaimenko et al. Non‐invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study
Farran et al. Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
Pallis et al. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34
Yanar Prognostic value of neutrophil to lymphocyte ratio and platelet indices in cats with feline panleukopenia

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]